CorMedix
CRMD
#6283
Rank
A$1.26 B
Marketcap
A$16.05
Share price
3.10%
Change (1 day)
6.66%
Change (1 year)

Operating Margin for CorMedix (CRMD)

Operating Margin as of December 2025 (TTM): 49.94%

According to CorMedix's latest financial reports and stock price the company's current Operating Margin is 49.94%. At the end of 2024 the company had an Operating Margin of -44.45%.

Operating Margin history for CorMedix from 2014 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-44.45%
2022-46,305.23%200.11%
2021-15,429.47%35.72%
2020-11,368.54%49.83%
2019-7,587.87%21.55%
2018-6,242.40%-37.72%
2017-10,023.45%-8.85%
2016-10,996.46%27.05%
2015-8,655.37%-19.9%
2014-10,806.25%-97.63%
2013-456,426.69%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Becton Dickinson
BDX
8.81%-82.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-14.09%-128.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
39.88%-20.14%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.